The possible reclassification of marijuana under the federal Controlled Substances Act is sparking debate about dismantling barriers to interstate commerce and the future of the industry.
While many states have created regulated marijuana markets for medical or recreational use or both, federal law remains a roadblock to nationwide market integration.
ADVERTISEMENT
According to a report called “Where Will Weed Win” by Robin Goldstein, director of the Cannabis Economics Group at the University of California, Davis, the future of the industry depends on federal regulatory outcomes.
The future of rescheduling or descheduling marijuana remains uncertain, with many executives and operators in the $32 billion marijuana industry wondering whether it will happen under the Trump administration.
“To deschedule, I’d be shocked if it happened in the
Read full article on Marijuana Business Daily
